Melanoma survivor T.J. Sharpe discusses the importance of clinical trials to help raise awareness among the community.
Deaths from malaria have been driven down by 60% since 2000. But unchecked drug resistance could cause more than 100,000 new deaths each year. Vas Narasimhan, CEO of Novartis, explains how we could avert this tragedy with decisive action.
Volunteerism and giving back to communities where we live and work are more than just tradition; they’re core values.
Survey results highlight the need for concerted action to guard against a fresh upsurge in the disease.
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
This site is intended for a global audience.